secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tenaya Therapeutics, Inc. (TNYA)
CIK:        0001858848
Form:       8-K
Filed at:   2022-06-10T23:59:59+00:00
Accession:  0000950170-22-011496
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tenaya Therapeutics reports stockholder votes from 2022 annual meeting
----------------------------------------------------------------------

- Four Class I directors elected: David Goeddel (34,063,079 for), Karah Parschauer (34,833,578), Jeffrey Walsh (34,112,810), R. Sanders Williams (34,135,556); 829,857 broker non-votes each.
- Ratification of Deloitte & Touche as independent auditor for FY2022: 35,984,423 for, 148 against, 244 abstain; no broker non-votes.
- All director nominees will serve until the 2025 annual meeting or until successors are elected.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858848/000095017022011496/0000950170-22-011496-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858848/000095017022011496/tnya-20220609.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-011496

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer